Mylan

Mylan receives approval from India, acquires Agila

Wednesday, September 4, 2013 03:53 PM

Global pharmaceutical company Mylan’s proposed acquisition of the Agila injectables businesses from Indian pharmaceutical company Strides Arcolab has received approval from India's Foreign Investment Promotion Board (FIPB). The transaction also received approval from the Cabinet Committee on Economic Affairs (CCEA). The transaction is expected to close in the fourth quarter of 2013.

More... »

Mylan to acquire Agila to create global injectables platform

Thursday, February 28, 2013 03:19 PM

Pittsburgh-based Mylan has signed a definitive agreement to acquire Agila Specialties Private Limited, a developer, manufacturer and marketer of high-quality generic injectable products, from Strides Arcolab for $1.6 billion in cash.

More... »

Biocon, Mylan enhance partnership with insulin products collaboration

Friday, February 15, 2013 11:45 AM

Biocon, a biotechnology company based in India, has formed a strategic collaboration with Mylan, a global pharmaceutical company, for for the global development and commercialization of generic versions of its three insulin analog products.

More... »

Pfizer, Mylan ink exclusive long-term collaboration for generics in Japan

Thursday, August 23, 2012 02:02 PM

Global research-based pharmaceutical company Pfizer and Canonsburg, Penn.-based pharmaceutical company Mylan have signed a definitive agreement to establish an exclusive long-term strategic collaboration to develop, manufacture, distribute and market generic drugs in Japan.

More... »

Mylan expands in Ireland, creates 500 jobs

Wednesday, April 18, 2012 02:54 PM

Mylan, a generics and specialty pharmaceutical company based in Canonsburg, Penn., will expand its operations in Dublin and Galway, Ireland, by investing up to $100 million over the next five years.

More... »

Burrill wraps up life sciences industry for Q1 2012

Wednesday, April 4, 2012 03:00 PM

Burrill & Company, a diversified global financial services firm focused on the life sciences industry, has identified more than $2.6 billion in expected funding through nine translational research and early-stage initiatives announced since the end of February.

More... »

Mylan names president of Dey Pharma

Monday, December 12, 2011 01:50 PM

Mylan has named John Thievon president of Dey Pharma, Mylan's pharmaceutical business.

More... »

Teva: Doctors being contacted for trial of Copaxone copy

Wednesday, March 9, 2011 01:34 PM

Doctors are being contacted to organize a clinical trial for a copy of Teva Pharmaceutical’s multiple sclerosis medicine Copaxone, according to a report in FiercePharma.

More... »